Altimmune said on Friday its experimental liver disease drug improved signs of scarring and health of the organ after 48 weeks of treatment in a mid-stage study, sending the company's shares up more ...
Altimmune said on Friday its experimental liver disease drug led to weight loss and improved markers for scarring and health of the organ based on non-invasive tests after 48 weeks of treatment in a ...
Everyday Health on MSN
Can Ozempic and other GLP-1s really increase your longevity?
These popular weight-loss drugs are already known for treating diabetes and helping people lose weight. Could they also add years to your life?
Eli Lilly and Co. announced Thursday, Dec. 18 that its experimental daily GLP-1 pill, orforglipron, successfully helped ...
Everyday Health on MSN
After GLP-1 Shots, This New Pill Helped People Keep the Weight Off
People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...
Novo Nordisk trades 32% below fair value with a 3.6% yield, semaglutide at 74% of sales, EPS rebound post '26, and pipeline ...
The debate over whether insurers should pay for GLP-1 drugs like Ozempic and Wegovy has revived a familiar American argument ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback